Oncogeni Deal17 Mar 2025 19:39
‘Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on developing first in class medicines in the high value and high growth immunology and oncology markets, is pleased to announce the signing of a term sheet for the proposed sale of its wholly owned subsidiary Oncogeni Ltd ("Oncogeni") to The Nations Trust Holding LLC ("Nations Trust") for a consideration cash amount of up to US$12 million (the "Term Sheet").‘
Can’t wait for this to land.